Wockhardt Limited
WOCKPHARMA.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$324.4B
Close$
$-109.40
105.5% downside
Current Fair Value
105.5% downsideOvervalued by 105.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $324.40 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $13.12 |
| Beta | 1 |
| Outstanding Shares | 162,492,169 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 79.35 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Wockhardt Limited
2,564 employees
CEO: Murtaza Khorakiwala Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades p...